GrantMetric / New Grants / November 2024
🆕 MONTHLY GRANT TRACKER

New Federal Grants — November 2024

112 federal grant opportunities posted in November 2024, sourced live from Grants.gov. Covers health, technology, environment, energy, defense, and more.

Posted in November 2024: 112 // Source: Grants.gov // Updated: Daily
← October 2024 November 2024 December 2024 →

About November 2024 Federal Grant Postings

Federal agencies post Notices of Funding Opportunity (NOFOs) throughout the year. Grants posted in November 2024 represent active funding from NIH, NSF, DOD, EPA, USDA, HHS, DOE, and other federal agencies. Each posting includes the award ceiling, eligibility requirements, and application deadline — all sourced directly from Grants.gov.

Newly posted grants are typically open for 30–90 days. High-priority programs from NIH and DOD often close faster — monitoring monthly postings ensures your organization does not miss time-sensitive opportunities. Bookmark this page and check back as new grants are added throughout the month.

How to use this list: Click any grant to view the full funding opportunity details including award ceiling, eligibility criteria, application instructions, and AI-generated briefing. Use the sector tags to identify relevant programs. All close dates are displayed in MM/DD/YYYY format and sourced directly from the official Grants.gov registry.

Grants Posted in November 2024 (112)

PA-25-245 09/07/2026
Alcohol Health Services Research (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-245) targets strategic development wit...

Posted: 11/27/2024 View Details →
PA-25-163 09/07/2026
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-163) targets strategic development wit...

Posted: 11/27/2024 View Details →
PAR-25-192 09/07/2026
Alcohol Health Services Research (R34 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-192) targets strategic development wi...

Posted: 11/27/2024 View Details →
PAR-25-193 09/07/2026
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-193) targets strategic development wi...

Posted: 11/27/2024 View Details →
PAR-25-183 10/15/2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-183) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-285 10/15/2027
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-285) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-177 10/15/2027
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-177) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-181 10/15/2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-181) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-178 10/15/2027
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-178) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-179 10/15/2027
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-179) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-182 10/15/2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-182) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-180 10/15/2027
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-180) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAR-25-184 10/15/2027
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-184) targets strategic development wi...

Posted: 11/26/2024 View Details →
PAS-25-208 05/07/2026
HIV Prevention and Alcohol (R01 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAS-25-208) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-272 05/07/2027
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-272) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-288 01/07/2028
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-288) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-159 01/07/2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-159) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-279 05/07/2027
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-279) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-289 01/07/2028
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-289) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-292 01/07/2028
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-292) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-158 11/17/2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-158) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAS-25-161 05/07/2026
HIV Prevention and Alcohol (R34 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAS-25-161) targets strategic development wi...

Posted: 11/25/2024 View Details →
PAR-25-281 01/07/2028
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-281) targets strategic development wi...

Posted: 11/22/2024 View Details →
RFA-HL-26-019 12/23/2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-HL-26-019) targets strategic development...

Posted: 11/22/2024 View Details →
PAR-25-291 01/07/2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-291) targets strategic development wi...

Posted: 11/22/2024 View Details →
PAR-25-282 01/07/2028
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-282) targets strategic development wi...

Posted: 11/22/2024 View Details →
PAR-25-290 01/07/2028
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-290) targets strategic development wi...

Posted: 11/22/2024 View Details →
RFA-HL-26-020 12/23/2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-HL-26-020) targets strategic development...

Posted: 11/22/2024 View Details →
RFA-HL-26-016 12/23/2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-HL-26-016) targets strategic development...

Posted: 11/22/2024 View Details →
PAR-25-226 11/19/2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-226) targets strategic development wi...

Posted: 11/22/2024 View Details →
RFA-OH-25-003 10/26/2028
Occupational Safety and Health Training Project Grants (T03)
Agency HHS-CDC-HHSCDCERA

High-priority technical directive issued by HHS-CDC-HHSCDCERA. This initiative (ID: RFA-OH-25-003) targets strategic dev...

Posted: 11/22/2024 View Details →
RFA-HL-26-018 12/23/2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-HL-26-018) targets strategic development...

Posted: 11/22/2024 View Details →
RFA-HL-26-017 12/23/2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-HL-26-017) targets strategic development...

Posted: 11/22/2024 View Details →
PAR-25-274 11/17/2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-274) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-268 11/17/2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-268) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-254 05/07/2026
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-254) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-286 01/07/2028
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-286) targets strategic development wi...

Posted: 11/21/2024 View Details →
RFA-NS-25-016 06/17/2026
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-NS-25-016) targets strategic development...

Posted: 11/21/2024 View Details →
PAR-26-001 05/07/2027
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-26-001) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-267 11/17/2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-267) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-248 10/08/2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-248) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-148 01/07/2028
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-148) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-287 01/07/2028
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-287) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-235 01/07/2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-235) targets strategic development wi...

Posted: 11/21/2024 View Details →
PAR-25-052 11/19/2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-052) targets strategic development wi...

Posted: 11/20/2024 View Details →
PAR-25-135 10/14/2027
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-135) targets strategic development wi...

Posted: 11/20/2024 View Details →
RFA-DA-26-034 11/18/2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-DA-26-034) targets strategic development...

Posted: 11/20/2024 View Details →
PAR-25-110 05/07/2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-110) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-111 05/07/2026
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-111) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-038 09/07/2026
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-038) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-066 09/07/2026
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-066) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-204 11/12/2027
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-204) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-112 09/07/2027
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-112) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-113 09/07/2027
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-113) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-176 05/07/2026
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-176) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-228 09/07/2027
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-228) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-229 09/07/2027
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-229) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-105 01/07/2028
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-105) targets strategic development wi...

Posted: 11/18/2024 View Details →
PA-25-125 01/07/2028
NICHD Small Research Grant Program (R03 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-125) targets strategic development wit...

Posted: 11/18/2024 View Details →
PAR-25-069 01/07/2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-069) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-243 01/07/2028
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-243) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-040 09/07/2026
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-040) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-095 09/07/2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-095) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-065 09/07/2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-065) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-070 01/07/2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-070) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-064 09/07/2026
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-064) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-096 09/07/2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-096) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-244 11/16/2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-244) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-166 05/07/2026
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-166) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-039 09/07/2026
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-039) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-067 09/07/2026
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-067) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-164 05/07/2026
NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-164) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-037 09/07/2026
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-037) targets strategic development wi...

Posted: 11/18/2024 View Details →
PAR-25-124 01/07/2028
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-124) targets strategic development wi...

Posted: 11/18/2024 View Details →
PA-25-126 05/24/2026
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-126) targets strategic development wit...

Posted: 11/18/2024 View Details →
PA-25-168 05/04/2028
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-168) targets strategic development wit...

Posted: 11/15/2024 View Details →
PAR-25-256 01/07/2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-256) targets strategic development wi...

Posted: 11/15/2024 View Details →
PAR-25-273 01/07/2028
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-273) targets strategic development wi...

Posted: 11/15/2024 View Details →
RFA-MH-26-170 02/08/2027
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-MH-26-170) targets strategic development...

Posted: 11/15/2024 View Details →
PAR-25-255 11/05/2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-255) targets strategic development wi...

Posted: 11/15/2024 View Details →
PAR-25-203 01/07/2028
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-203) targets strategic development wi...

Posted: 11/14/2024 View Details →
PAR-25-202 01/07/2028
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-202) targets strategic development wi...

Posted: 11/14/2024 View Details →
RFA-ES-25-002 04/20/2027
Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-ES-25-002) targets strategic development...

Posted: 11/14/2024 View Details →
25-510 03/03/2027
Coupling, Energetics, and Dynamics of Atmospheric Regions
Agency NSF

High-priority technical directive issued by NSF. This initiative (ID: 25-510) targets strategic development within the P...

Posted: 11/14/2024 View Details →
PAR-25-170 06/22/2026
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-170) targets strategic development wi...

Posted: 11/13/2024 View Details →
PAR-25-027 01/07/2028
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-027) targets strategic development wi...

Posted: 11/12/2024 View Details →
PA-25-253 09/07/2028
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-253) targets strategic development wit...

Posted: 11/12/2024 View Details →
PAR-25-167 01/07/2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-167) targets strategic development wi...

Posted: 11/12/2024 View Details →
PAR-25-081 01/07/2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-081) targets strategic development wi...

Posted: 11/12/2024 View Details →
PAR-25-136 01/07/2028
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-136) targets strategic development wi...

Posted: 11/07/2024 View Details →
PA-25-172 01/07/2028
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PA-25-172) targets strategic development wit...

Posted: 11/07/2024 View Details →
PAR-25-234 01/07/2028
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-234) targets strategic development wi...

Posted: 11/07/2024 View Details →
PAR-25-049 07/09/2026
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-049) targets strategic development wi...

Posted: 11/07/2024 View Details →
PAR-25-221 01/07/2027
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-221) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-227 01/07/2028
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-227) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-145 01/07/2028
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-145) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-24-325 09/07/2027
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-24-325) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-24-306 09/07/2026
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-24-306) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-153 09/07/2026
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-153) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-24-311 01/07/2028
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-24-311) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-175 01/07/2028
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-175) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-036 05/07/2026
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-036) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-24-321 11/12/2027
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-24-321) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAS-25-205 01/06/2028
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAS-25-205) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-063 05/07/2026
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-063) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-079 01/07/2027
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-079) targets strategic development wi...

Posted: 11/06/2024 View Details →
PAR-25-103 10/25/2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-103) targets strategic development wi...

Posted: 11/05/2024 View Details →
RFA-NS-25-022 09/28/2026
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-NS-25-022) targets strategic development...

Posted: 11/05/2024 View Details →
PAR-25-104 10/25/2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-104) targets strategic development wi...

Posted: 11/05/2024 View Details →
RFA-NS-25-021 09/28/2026
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: RFA-NS-25-021) targets strategic development...

Posted: 11/05/2024 View Details →
PAR-25-225 10/20/2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-225) targets strategic development wi...

Posted: 11/04/2024 View Details →
PAR-25-077 10/16/2026
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
Agency HHS-NIH11

High-priority technical directive issued by HHS-NIH11. This initiative (ID: PAR-25-077) targets strategic development wi...

Posted: 11/01/2024 View Details →
Browse More

See grants closing soon or explore the full intelligence feed.

⏱ Closing Soon → All Months → Intelligence Feed →
GrantMetric Intelligence Systems — Independent federal grant intelligence platform. Not affiliated with Grants.gov, the U.S. Department of Health & Human Services, or any government agency. Grant data is sourced from the Grants.gov API for informational purposes only; always verify opportunity details directly with the funding agency before applying. Some links on this site are affiliate links — we may earn a commission at no additional cost to you. Full Disclaimer  ·  Last Reviewed: May 2026  ·  Data Methodology